Polydopamine–Mesoporous Silica Core–Shell Nanoparticles for Combined Photothermal Immunotherapy
- 8 September 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 12 (38) , 42499-42510
Abstract
Cancer immunotherapy involves a cascade of events that ultimately leads to cytotoxic immune cells effectively identifying and destroying cancer cells. Responsive nanomaterials, which enable spatiotemporal orchestration of various immunological events for mounting a highly potent and long-lasting anti-tumor immune response, are an attractive platform to overcome challenges associated with existing cancer immunotherapies. Here, we report a multifunctional near infrared (NIR)-responsive core-shell nanoparticle, which enables (i) photothermal ablation of cancer cells for generating tumor associated antigen (TAA) and (ii) triggered release of an immunomodulatory drug (gardiquimod) for starting a series of immunological events. The core of these nanostructures is composed of polydopamine nanoparticle, which serves as a photothermal agent, and the shell is made of mesoporous silica, which serves as a drug carrier. We employed a phase-change material as gatekeeper to achieve concurrent release of both TAA and adjuvant, thus efficiently activating the antigen presenting cells (APCs). Photothermal-immunotherapy enabled by these nanostructures resulted in regression of primary tumor and significantly improved inhibition of secondary tumor in a mouse melanoma model. These biocompatible, biodegradable, and NIR-responsive core-shell nanostructures simultaneously deliver payload and cause photothermal ablation of the cancer cells. Our results demonstrate potential of responsive nanomaterials in generating highly synergistic photothermal-immunotherapeutic response.Keywords
Funding Information
- National Cancer Institute (R01 CA141521, R21 CA236652)
This publication has 58 references indexed in Scilit:
- Induction of pro-inflammatory cytokine production in thymocytes by the immune response modifiers Imiquimod and Gardiquimod™International Immunopharmacology, 2013
- Monitoring Controlled Release of Payload from Gold Nanocages Using Surface Enhanced Raman ScatteringACS Nano, 2013
- Targeting mesoporous silica-encapsulated gold nanorods for chemo-photothermal therapy with near-infrared radiationBiomaterials, 2013
- A New Theranostic System Based on Gold Nanocages and Phase-Change Materials with Unique Features for Photoacoustic Imaging and Controlled ReleaseJournal of the American Chemical Society, 2011
- Lymph node mapping in the mouseJournal of Immunological Methods, 2008
- Mussel-Inspired Surface Chemistry for Multifunctional CoatingsScience, 2007
- Interactions of tumor cells with dendritic cells: balancing immunity and toleranceCell Death & Differentiation, 2007
- Tumoricidal activity of TLR7/8-activated inflammatory dendritic cellsJournal of Experimental Medicine, 2007
- Biological Significance of Isolated Tumor Cells and Micrometastasis in Lymph Nodes Evaluated Using a Green Fluorescent Protein–Tagged Human Gastric Cancer Cell LineClinical Cancer Research, 2006
- Cancer immunoediting: from immunosurveillance to tumor escapeNature Immunology, 2002